Pressure Biosciences (PBIO) 0.4000

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pressure Biosciences (PBIO) 0.4000 $PBIO

StockNewsNow.com Publishes Business and Earnings Review Q1 2016 with Pressure BioSciences, Inc.
PR Newswire - Thu Jun 02, 6:54AM CDT
StockNewsNow.com, The Official MicroCap News Source(TM), today published an SNNLive Newscast - Business and Earnings Review with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO), a life sciences company that develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market, according to the Company's website (see here: www.PressureBioSciences.com). The video interview was recorded on Friday, May 20th, 2016 via Skype from SNN's office in Los Angeles, CA and Pressure BioSciences' headquarters in Boston, MA.

WallStreet Research(TM) Announces Availability of Updated Corporate Profile Coverage On Pressure BioSciences, Inc. (OTCQB: PBIO)
ACCESSWIRE - Tue May 31, 9:01PM CDT
NEW YORK, NY / ACCESSWIRE / May 31, 2016 / WallStreet Research™, a top-ranked independent research firm with a history spanning over three decades, today announced that the firm has updated corporate profile coverage on Pressure BioSciences, Inc. (OTCQB: PBIO). WallStreet Research™ is ranked number one on the Google, Yahoo, and Bing search engines in both and small and microcap research. An updated analyst Corporate Profile Report, together with additional information about WallStreet Research™, is available at the www.WallStreetResearch.org website.
DHR: 81.23 (-0.16)

OTCQX and OTCQB Companies to Present at 2016 Marcum MicroCap Conference
PR Newswire - Tue May 31, 5:49PM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the Marcum MicroCap Conference, taking place June 1-2nd at the Grand Hyatt New York. The Marcum MicroCap Conference, is dedicated to providing a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The Conference will feature presentations by CEOs and CFOs from various industry sectors, expert panels, and the opportunity to meet with management of presenting companies on a one-on-one basis.
LTEA: 4.24 (-0.07)

SeeThruEquity Issues Update on Pressure BioSciences (OTCQB: PBIO), Raises Price Target to $1.75
ACCESSWIRE - Thu May 26, 8:00AM CDT
NEW YORK, NY / ACCESSWIRE / May 26, 2016 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued an update on Pressure BioSciences, Inc. (OTCQB: PBIO).
DHR: 81.23 (-0.16)

SECFilings.com Reports on Pressure BioSciences' Q1 2016 Financial Results
Marketwire Canada - Wed May 25, 11:07AM CDT
REDONDO BEACH, CA--(Marketwired - May 25, 2016) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, takes a deeper dive into Pressure BioSciences Inc.'s (OTCQB: PBIO) recently filed first quarter 2016 financial results.

Pressure BioSciences, Inc. Reports First Quarter 2016 Financial Results and Provides Business Update
PR Newswire - Wed May 18, 11:33AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced financial results for the 2016 first quarter ended March 31, 2016, provided a business update, and offered limited guidance for the remainder of FY2016.

Pressure BioSciences Added to the High-Performing Richmond Club Index; Richmond Index Has Outperformed the S&P 500 Index by an Average of 11% Each Year for the Past Ten Years
PR Newswire - Tue Apr 12, 11:18AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company", a leader in the development and sale of broadly enabling pressure cycling technology ("PCT"-based sample preparation solutions to the worldwide life sciences industry, today announced it has been added to the Richmond Club Index, which has outperformed the S&P 500 Index by an average of 11% each year since its inception ten years ago. The Richmond Club boasts roughly 550 members, comprised of a mix of investment advisors, fund managers, analysts, and members of the media.

Pressure BioSciences Closes Additional $769K in PIPE Financing; Final Close Brings Total Raised to Over $6.3 Million, Substantially Above Company's Goal of $5 Million
PR Newswire - Thu Apr 07, 10:05AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company", a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT"-based sample preparation solutions to the worldwide life sciences industry, today announced the receipt of $769,667 in the final close of its $5 Million PIPE Financing (the "Offering". This final closing increased the total raised in the Offering to $6,329,667, an amount substantially above the Company's goal of $5 Million. The Company netted $719,049 in cash from the final close and $5,101,049 in cash from the total Offering.

Pressure BioSciences, Inc. Reports Fiscal Year 2015 Financial Results and Provides Business Update
PR Newswire - Wed Apr 06, 9:46AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced financial results for the fiscal year ended December 31, 2015, provided a business update, and offered limited guidance for FY2016.

Pressure BioSciences to Participate in SCIEX Workshop on New Innovations Towards Industrialized Proteomics at US HUPO Conference
PR Newswire - Mon Mar 14, 8:17AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company", a leader in the development and sale of broadly enabling pressure cycling technology ("PCT"-based sample preparation solutions to the worldwide life sciences industry, today announced that SCIEX, a global leader in life science analytical technologies, will present and lead a precision medicine workshop on "New Innovations Towards Industrialized Proteomics" at the annual conference of the US Human Proteome Organization ("US HUPO". US HUPO is being held from March 13-16 in Boston, MA. Representatives from SCIEX, Pressure BioSciences, Inc., and Advaita Bioinformatics will share insightful examples of how SCIEX next-generation solutions are enabling life science researchers to unlock the potential of their discoveries using industrialized omics to enable precision medicine. The workshop will showcase examples of how SCIEX's next-generation mass spectrometry-based solutions, combined with PBI's PCT platform and Advaita's iPathwayGuide, provide the ability to industrialize omics research workflows.

StockNewsNow.com Publishes SNNLive Video Interview Q1 2016 Update With Pressure Biosciences, Inc.
Marketwired - Tue Feb 09, 8:04AM CST
StockNewsNow.com, The Official MicroCap News Source(TM), today published an SNNLive Video Interview with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO), a life sciences company that develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market, according to the Company's website (see here: www.PressureBioSciences.com). The video interview was recorded at the SeeThruEquity Annual MicroCap Healthcare Investor Conference 2016 in San Francisco, CA on January 11th, 2016.

Pressure BioSciences' SCIEX Deal Could Dramatically Accelerate Revenue
ACCESSWIRE - Thu Jan 28, 8:26AM CST
REDONDO BEACH, CA / ACCESSWIRE / January 28, 2016 / SCIEX, a global leader in life science analytical technologies, and a wholly-owned subsidiary of Danaher Corporation (NYSE: DHR), recently announced an exclusive co-marketing agreement with Pressure BioSciences, Inc. (OTCQB: PBIO). PBIO is a worldwide leader in the development and sale of pressure cycling technology (PCT)-based sample preparation systems to the life sciences research market. Under the agreement, the companies will jointly promote PBIO's PCT-based sample preparation systems and SCIEX's mass spectrometry equipment, with a focus on improved sample preparation, a crucial step performed by hundreds of thousands of research laboratories worldwide. This combination of technologies could result in superior biological insights and discoveries in the life sciences industry, and in rapid and dramatic revenue growth for PBIO.
NSTG: 16.47 (unch), A: 48.44 (+0.30), TMO: 155.97 (+0.48), NEO: 8.10 (+0.08), QGEN: 27.55 (+0.33), DHR: 81.23 (-0.16), WAT: 159.14 (+0.89)

Investors Flock to Pressure BioSciences as Its Patented PCT Platform Goes Mainstream
ACCESSWIRE - Fri Jan 15, 8:35AM CST
REDONDO BEACH, CA / ACCESSWIRE / January 15, 2016 / Pressure BioSciences Inc. (OTCQB: PBIO) just announced that it exceeded its $5 million fundraising goal and approved the opening of an additional $1.25 million over-subscription amount in its PIPE offering. With growing revenue, a new multi-national partner (see below), and a potential up-listing in the near future, accredited investors have been flocking into the company's stock through the private offering, and retail investors have been flocking into the company's stock in the open market. Both of these may be bullish signs for individual investors for the coming year.
HBIO: 2.61 (-0.04), TMO: 155.97 (+0.48), HTGM: 2.40 (+0.16), DHR: 81.23 (-0.16), WAT: 159.14 (+0.89)

WallStreet Research(TM) Announces Availability of Updated Corporate Profile Coverage On Pressure BioSciences, Inc. (PBIO)
ACCESSWIRE - Wed Jan 13, 6:00AM CST
NEW YORK, NY / ACCESSWIRE / January 13, 2016 / WallStreet Research(TM), a top-ranked independent research firm with a history spanning over three decades, today announced that the firm has updated corporate profile coverage on Pressure BioSciences, Inc. (OTCQBBIO). WallStreet Research(TM) is ranked number one on the Google, Yahoo, and Bing search engines in both and small and microcap research. The analyst corporate profile report, together with additional information about WallStreet Research(TM), is available at the www.WallStreetResearch.org website.

Pressure BioSciences Exceeds $5 Million PIPE Goal and Opens $1.25 Million Over-Subscription Amount
PR Newswire - Mon Jan 11, 9:43AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company", a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT"-based sample preparation solutions to the worldwide life sciences industry, today announced it has exceeded its $5 million PIPE goal following the receipt of $255,000 in gross proceeds from the fifth closing of its $5 million Private Placement (the "Offering". This closing increased the total amount raised in the Offering to $5,010,000.

Pressure BioSciences Cleans Up Balance Sheet with Successful PIPE Financing
ACCESSWIRE - Wed Dec 16, 8:20AM CST
Improved Balance Sheet Paves Way for Increased Revenue, Potential Uplisting and Stronger Shareholder Value
HBIO: 2.61 (-0.04), NSTG: 16.47 (unch)

Three Reasons Investors Should Consider Pressure BioSciences
ACCESSWIRE - Wed Dec 02, 8:20AM CST
REDONDO BEACH, CA / ACCESSWIRE / December 2, 2015 / Pressure BioSciences Inc. (OTCQB: PBIO) is a developer of life science tools (e.g., instruments and consumables) for researchers around the world. By gently squeezing cells rather than mechanically breaking them open with "one-size-fits-all" tools, the company's innovative PCT platform enables scientists to quickly release and isolate the proteins on which they need to conduct research, but without damaging them. These proteins can then be put into mass spectrometry and other equipment to potentially make valuable, even life-changing scientific discoveries.
FLDM: 9.08 (+0.08), MRK: 63.32 (-0.03), AMGN: 174.58 (+1.56)

WallStreet Research Announces Availability of Corporate Profile Coverage on Pressure BioSciences Inc. (PBIO), Released at www.WallStreetResearch.org
Marketwired - Mon Nov 30, 6:00AM CST
WallStreet Research(TM), a top-ranked independent research firm with a history spanning over three decades, today announced that the firm has initiated corporate profile coverage on Pressure BioSciences, Inc. (OTCQB: PBIO). The analyst corporate profile report, together with additional information about WallStreet Research(TM), is available at the www.WallStreetResearch.org website.

StockNewsNow.com Publishes SNNLive Video Interview Update with Pressure BioSciences, Inc.
Marketwired - Mon Nov 23, 7:37AM CST
StockNewsNow.com, The Official MicroCap News Source(TM), today published an SNNLive Video Interview with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO), a life sciences company that develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market, according to the Company's website (see here: www.PressureBioSciences.com). The video interview was recorded at the SeeThruEquity MicroCap Investor Forum on November 12th, 2015 in New York City, NY.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elite Robots Expands Global Reach with Mobile Manipulators

Updated Category News Views 105

Robots Hitting the Road? Picture this: robots that aren't just bolted to a factory floor but roam the production lines like tireless workers on wheels. That's what Elite Robots is betting on with their shiny new ELITEMISSION mobile manipulators. Not Just Any Old Robot These bad boys combine a robotic arm with an autonomous mobile platform. Think of an octopus getting off...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 228

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 13

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 147

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 29

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 28

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading
ICEYE Launches Gen5 SAR Satellite for Unrivaled Clarity

Updated Category News Views 60

Well, if you've been sleeping under a rock and missed the news, ICEYE just dropped another bombshell in the satellite biz. Gen5 is the name of the game, and it's claiming the spotlight for its razor-sharp imaging prowess. Now, we're talking about a satellite that supposedly snaps pictures with a resolution as fine as 11 cm. That's like spotting a flea on a dog's back from...

Continue Reading
Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 47

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading
2GenPen's Patent Push: Transforming Credit Analysis

Updated Category News Views 7

Changing the Game in Credit Analysis When you hear about a company snagging a patent, it's usually a big whoop-de-do; but 2GenPen's latest achievement is making some serious waves. This isn't some 'pat-yourself-on-the-back' sort of news – it's got teeth in the world of finance. These folks just locked down their second U.S. patent, number 12,784,096, and it's all about...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 131

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Innovation: Schneider Electric's Climate Tech Event

Updated Category News Views 170

Exploring the Excitement of the Climate Tech in the City Event The Climate Tech in the City event embodies the spirit of innovation, uniting key players in the climate technology sector. Leading organizations like Schneider Electric are at the forefront, showcasing groundbreaking advancements and sustainable practices. This year's gathering promises a vibrant day filled...

Continue Reading
Ouster Transforms Chattanooga into a Smart Traffic Hub

Updated Category News Views 404

Ouster's Groundbreaking Initiative in Smart Traffic Management In a significant development for urban traffic management, Ouster, Inc. (NASDAQ: OUST), recognized for its state-of-the-art lidar sensors, has launched a transformative project in Chattanooga. This venture stands out as the largest lidar-enabled traffic system in the United States, boasting a remarkable...

Continue Reading
Bicara Therapeutics Business Highlights and Q1 2025 Financial Review

Updated Category News Views 520

Bicara Therapeutics Announces Key Developments and Q1 2025 Financial Results Latest data from ongoing clinical trials to be showcased at upcoming conferences. Strong financial position enables sustained development through 2029. Bicara Therapeutics Inc. (Nasdaq: BCAX), a pioneering clinical-stage biopharmaceutical firm, focuses on delivering groundbreaking bifunctional...

Continue Reading
IO Biotech Gears Up for December Conferences: Insights and Highlights

Updated Category News Views 148

IO Biotech Prepares for Key Investor Conferences IO Biotech, a trailblazer in developing groundbreaking immune-modulatory cancer vaccines, is set to join two prominent investor events this December. The company, listed under NASDAQ: IOBT, is known for its innovative approach in the biopharmaceutical industry, particularly in creating off-the-shelf therapeutic cancer...

Continue Reading
Cardinal Energy Secures $40 Million Through Latest Debenture Offering

Updated Category News Views 267

Cardinal Energy Ltd. Announces a Major Offering Cardinal Energy Ltd. is excited to inform investors about its latest initiative aimed at raising funds through a significant offering. The company has entered into an agreement with a selected group of underwriters who will help facilitate the sale of $40 million in senior subordinated unsecured debentures. This strategic...

Continue Reading